Related Experiment Video
Updated: Aug 4, 2026

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
[14C]urea breath test for diagnosis of Helicobacter pylori
J E Ormand1, N J Talley, H A Carpenter
1Department of Surgical Pathology, Mayo Clinic, Rochester, MN 55905.
Insights
This study validates a shorter, age-adjusted 14C-urea breath test for diagnosing H. pylori infections. Incorporating patient age improves accuracy, especially for older individuals, and shortens test time to 30 minutes.
Area of Science:
- Gastroenterology
- Medical Diagnostics
- Microbiology
Background:
- Helicobacter pylori (H. pylori) is a urease-producing bacterium.
- Urea breath tests (UBTs) like the 14C-UBT are used to detect H. pylori infections.
- H. pylori prevalence increases with age, but age is not typically used in UBT interpretation.
Purpose of the Study:
- To validate a shortened, age-adjusted 14C-urea breath test for H. pylori diagnosis.
- To assess the impact of patient age on 14C-UBT results.
- To determine if age adjustment can optimize H. pylori detection.
Main Methods:
- Forty-one subjects (volunteers and patients) underwent esophagogastroduodenoscopy with biopsies for H. pylori confirmation.
- All subjects completed a 120-minute 14C-urea breath test.
- Logistic regression analysis, adjusting for age, was used to interpret 14C values and H. pylori status.
Main Results:
- The 14C-UBT was validated as a sensitive and specific test for H. pylori.
- Test results between 15 and 80 minutes were equally predictive.
- Advancing age correlated with a higher probability of H. pylori positivity.
- Age adjustment allowed accurate diagnosis of H. pylori in older patients at lower 14C values.
Conclusions:
- The 14C-urea breath test can be abbreviated to a 30-minute examination.
- Patient age is a significant factor for optimizing 14C-UBT interpretation.
- Further studies are needed to confirm the age-adjustment model for H. pylori diagnosis.
Abstract:
H. pylori is a potent urease producer, a characteristic that has been exploited in the development of the [14C]- and [13C]urea breath tests. The prevalence of H. pylori infection also is known to increase with advancing age; however, the individual patient's age has not routinely been considered when interpreting urea breath test results. The aim of this study was to validate a short, age-adjusted [14C]urea breath test for use in diagnosing H. pylori infections. Forty-one subjects (28 volunteers, 13 patients) underwent esophagogastroduodenoscopy with biopsies. Subjects were defined as being H. pylori-positive if histology or culture was positive. In addition, all subjects completed a 120-min [14C]urea breath test. A logistic regression analysis adjusting for age was used to estimate the probability of H. pylori positivity as a function of the 14C values generated. Sixteen subjects were H. pylori-positive, and 25 were H. pylori-negative. The 14C values generated between 15 and 80 min were found to be equally predictive in identifying H. pylori-positive subjects. Advancing age was associated with a higher probability of H. pylori-positivity. By taking advantage of the statistical probabilities, older patients could be accurately diagnosed with H. pylori at lower 14C values. We found that [14C]urea breath test to be both a sensitive and specific test that can be abbreviated to a 30-min examination (total test time). Moreover, our mathematical model indicates that a patient's age should be considered in order to optimize interpretation of the [14C]urea breath test, although further observations are needed to confirm this model.
More Related Videos
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Serum Laboratory Studies, Stool Test, Breath Test
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology